Review





Similar Products

94
Bioss rabbit anti vegf a
Rabbit Anti Vegf A, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti vegf a/product/Bioss
Average 94 stars, based on 1 article reviews
rabbit anti vegf a - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

96
Proteintech rabbit anti vegf polyclonal ab
Rabbit Anti Vegf Polyclonal Ab, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti vegf polyclonal ab/product/Proteintech
Average 96 stars, based on 1 article reviews
rabbit anti vegf polyclonal ab - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

94
Bioss rabbit anti vegf
Rabbit Anti Vegf, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti vegf/product/Bioss
Average 94 stars, based on 1 article reviews
rabbit anti vegf - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

94
Bioss rabbit anti vegf antibody
Rabbit Anti Vegf Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit anti vegf antibody/product/Bioss
Average 94 stars, based on 1 article reviews
rabbit anti vegf antibody - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Santa Cruz Biotechnology rabbit polyclonal antibody vegf sc-152
Rabbit Polyclonal Antibody Vegf Sc 152, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal antibody vegf sc-152/product/Santa Cruz Biotechnology
Average 90 stars, based on 1 article reviews
rabbit polyclonal antibody vegf sc-152 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Thermo Fisher polyclonal rabbit anti-vegf antibody pa5-16754
Effect of SAF-AuNPs/DOX-AuNPs combination therapy on hepatic <t>VEGF</t> expression. a Immunohistochemical-stained liver sections of VEGF, black arrows illustrate VEGF expression areas. X200, bar = 50 µm. b VEGF percentage of positive cells in hepatic tissue. Results were presented as mean ± SEM. n = 8 rats per group. + p < 0.05 vs. control group, # p < 0.05 vs. HCC group, * p < 0.05 vs. Plain-AuNPs i.p. group, & p < 0.05 vs. Plain-AuNPs oral group, $ p < 0.05 vs. SAF group @ p < 0.05 vs. DOX group, ~ p < 0.05 vs. SAF-AuNPs group, = p < 0.05 vs. DOX-AuNPs group
Polyclonal Rabbit Anti Vegf Antibody Pa5 16754, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/polyclonal rabbit anti-vegf antibody pa5-16754/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
polyclonal rabbit anti-vegf antibody pa5-16754 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

96
Santa Cruz Biotechnology rabbit polyclonal vegf antibody a 20
Effect of SAF-AuNPs/DOX-AuNPs combination therapy on hepatic <t>VEGF</t> expression. a Immunohistochemical-stained liver sections of VEGF, black arrows illustrate VEGF expression areas. X200, bar = 50 µm. b VEGF percentage of positive cells in hepatic tissue. Results were presented as mean ± SEM. n = 8 rats per group. + p < 0.05 vs. control group, # p < 0.05 vs. HCC group, * p < 0.05 vs. Plain-AuNPs i.p. group, & p < 0.05 vs. Plain-AuNPs oral group, $ p < 0.05 vs. SAF group @ p < 0.05 vs. DOX group, ~ p < 0.05 vs. SAF-AuNPs group, = p < 0.05 vs. DOX-AuNPs group
Rabbit Polyclonal Vegf Antibody A 20, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal vegf antibody a 20/product/Santa Cruz Biotechnology
Average 96 stars, based on 1 article reviews
rabbit polyclonal vegf antibody a 20 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

96
Proteintech rabbit polyclonal antibodies against vegfa
Figure 1. Identification of <t>Vegfa</t> as a direct target of miR-29a-3p in VSMCs using bioinformatics and dual-luciferase assay. (A) Venn diagram depicting the overlap of miR-29a-3p target genes predicted by four miRNA target prediction tools: miRTarBase, miRWalk, TargetScan, and miRDB. The box highlights the seven genes identified as common targets across all tools. (B) Sequence alignment of miR-29a-3p with the 3′-UTR region of wild-type and mutated Vegfa mRNA. The predicted binding site and seed region are marked in red. (C) Dual-luciferase reporter assay results for VSMCs co-transfected with a control vector, a vector containing the wild type (WT) Vegfa 3′-UTR sequence, or the MUT Vegfa sequence, along with miR-29a-3p mimics or a negative control miRNA (NT). Relative luciferase activity was measured, and data are presented as mean ± SD from three independent experiments.
Rabbit Polyclonal Antibodies Against Vegfa, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal antibodies against vegfa/product/Proteintech
Average 96 stars, based on 1 article reviews
rabbit polyclonal antibodies against vegfa - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier

Image Search Results


Effect of SAF-AuNPs/DOX-AuNPs combination therapy on hepatic VEGF expression. a Immunohistochemical-stained liver sections of VEGF, black arrows illustrate VEGF expression areas. X200, bar = 50 µm. b VEGF percentage of positive cells in hepatic tissue. Results were presented as mean ± SEM. n = 8 rats per group. + p < 0.05 vs. control group, # p < 0.05 vs. HCC group, * p < 0.05 vs. Plain-AuNPs i.p. group, & p < 0.05 vs. Plain-AuNPs oral group, $ p < 0.05 vs. SAF group @ p < 0.05 vs. DOX group, ~ p < 0.05 vs. SAF-AuNPs group, = p < 0.05 vs. DOX-AuNPs group

Journal: Discover Oncology

Article Title: Safranal-loaded gold nanoparticles alleviate hepatocellular carcinoma via targeting the Wnt/β-catenin pathway

doi: 10.1007/s12672-025-02447-w

Figure Lengend Snippet: Effect of SAF-AuNPs/DOX-AuNPs combination therapy on hepatic VEGF expression. a Immunohistochemical-stained liver sections of VEGF, black arrows illustrate VEGF expression areas. X200, bar = 50 µm. b VEGF percentage of positive cells in hepatic tissue. Results were presented as mean ± SEM. n = 8 rats per group. + p < 0.05 vs. control group, # p < 0.05 vs. HCC group, * p < 0.05 vs. Plain-AuNPs i.p. group, & p < 0.05 vs. Plain-AuNPs oral group, $ p < 0.05 vs. SAF group @ p < 0.05 vs. DOX group, ~ p < 0.05 vs. SAF-AuNPs group, = p < 0.05 vs. DOX-AuNPs group

Article Snippet: After that, they were incubated with polyclonal rabbit anti-VEGF antibody (Thermo Fisher Scientific, Cat. No. PA5-16754, dilution 1/100), after rinsing with PBS, they were incubated with a goat anti-rabbit secondary antibody (Cat. No. K4003, EnVision + TM System Horseradish Peroxidase Labelled Pomer; Dako) for 30 min at room temperature.

Techniques: Expressing, Immunohistochemical staining, Staining, Control

Figure 1. Identification of Vegfa as a direct target of miR-29a-3p in VSMCs using bioinformatics and dual-luciferase assay. (A) Venn diagram depicting the overlap of miR-29a-3p target genes predicted by four miRNA target prediction tools: miRTarBase, miRWalk, TargetScan, and miRDB. The box highlights the seven genes identified as common targets across all tools. (B) Sequence alignment of miR-29a-3p with the 3′-UTR region of wild-type and mutated Vegfa mRNA. The predicted binding site and seed region are marked in red. (C) Dual-luciferase reporter assay results for VSMCs co-transfected with a control vector, a vector containing the wild type (WT) Vegfa 3′-UTR sequence, or the MUT Vegfa sequence, along with miR-29a-3p mimics or a negative control miRNA (NT). Relative luciferase activity was measured, and data are presented as mean ± SD from three independent experiments.

Journal: Renal Failure

Article Title: miR-29a-3p/ Vegfa axis modulates high phosphate-induced vascular smooth muscle cell calcification

doi: 10.1080/0886022x.2025.2489712

Figure Lengend Snippet: Figure 1. Identification of Vegfa as a direct target of miR-29a-3p in VSMCs using bioinformatics and dual-luciferase assay. (A) Venn diagram depicting the overlap of miR-29a-3p target genes predicted by four miRNA target prediction tools: miRTarBase, miRWalk, TargetScan, and miRDB. The box highlights the seven genes identified as common targets across all tools. (B) Sequence alignment of miR-29a-3p with the 3′-UTR region of wild-type and mutated Vegfa mRNA. The predicted binding site and seed region are marked in red. (C) Dual-luciferase reporter assay results for VSMCs co-transfected with a control vector, a vector containing the wild type (WT) Vegfa 3′-UTR sequence, or the MUT Vegfa sequence, along with miR-29a-3p mimics or a negative control miRNA (NT). Relative luciferase activity was measured, and data are presented as mean ± SD from three independent experiments.

Article Snippet: VSMCs recovered by centrifugation were homogenized and separated using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (China National Pharmaceutical Group Corporation Chemical reagent Co., Ltd., China; Cat. #30166428). the proteins were then transferred to polyvinylidene fluoride membranes (Millipore Co., uSa; Cat. #ISEQ00010). the blots were stained with rabbit polyclonal antibodies against VEGFa (1:10,000; Proteintech, uSa; Cat. #19003-1-aP), and mouse monoclonal antibodies against β-actin (1:10,000, Servicebio, China; Cat. #Gb15001), followed by anti-rabbit IgG (1:10,000, SIMubIotECH, China; Cat. #S2001), and anti-mouse IgG horseradish peroxidase conjugates (1:10,000, abclonal, China; Cat. #aS003).

Techniques: Luciferase, Sequencing, Binding Assay, Reporter Assay, Transfection, Control, Plasmid Preparation, Negative Control, Activity Assay

Figure 2. miR-29a-3p overexpression suppresses Vegfa expression in VSMCs. (A) Representative Western blot analysis of VEGFA protein levels in VSMCs under standard culture conditions (control), high phosphate conditions (Pi), and high phosphate conditions following miR-29a-3p overexpression (Pi + miR-29a-3p). β-actin served as a loading control. Quantitative analysis of VEGFA protein levels is shown as relative fold change normalized to β-actin. (B) Vegfa mRNA levels quantified using RT-qPCR in the same experimental groups. GAPDH was used as an internal control for normalization. Data represent the mean ± SD of five independent biological replicates.

Journal: Renal Failure

Article Title: miR-29a-3p/ Vegfa axis modulates high phosphate-induced vascular smooth muscle cell calcification

doi: 10.1080/0886022x.2025.2489712

Figure Lengend Snippet: Figure 2. miR-29a-3p overexpression suppresses Vegfa expression in VSMCs. (A) Representative Western blot analysis of VEGFA protein levels in VSMCs under standard culture conditions (control), high phosphate conditions (Pi), and high phosphate conditions following miR-29a-3p overexpression (Pi + miR-29a-3p). β-actin served as a loading control. Quantitative analysis of VEGFA protein levels is shown as relative fold change normalized to β-actin. (B) Vegfa mRNA levels quantified using RT-qPCR in the same experimental groups. GAPDH was used as an internal control for normalization. Data represent the mean ± SD of five independent biological replicates.

Article Snippet: VSMCs recovered by centrifugation were homogenized and separated using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (China National Pharmaceutical Group Corporation Chemical reagent Co., Ltd., China; Cat. #30166428). the proteins were then transferred to polyvinylidene fluoride membranes (Millipore Co., uSa; Cat. #ISEQ00010). the blots were stained with rabbit polyclonal antibodies against VEGFa (1:10,000; Proteintech, uSa; Cat. #19003-1-aP), and mouse monoclonal antibodies against β-actin (1:10,000, Servicebio, China; Cat. #Gb15001), followed by anti-rabbit IgG (1:10,000, SIMubIotECH, China; Cat. #S2001), and anti-mouse IgG horseradish peroxidase conjugates (1:10,000, abclonal, China; Cat. #aS003).

Techniques: Over Expression, Expressing, Western Blot, Control, Quantitative RT-PCR

Figure 3. Vegfa knockdown and miR-29a-3p overexpression mitigate high phosphate-induced VSMCs calcification. (A–C) Analysis of Vegfa knockdown effects in VSMCs cultured in normal media (control) or high phosphate conditions (Pi). (A) Vegfa mRNA levels were quantified via RT-qPCR. (B) ARS with corresponding spectrophotometric quantification to assess cellular mineralization. (C) Quantification of intracellular Ca2+ content. Cells were treated with small interfering RNA targeting Vegfa (siVegfa) or a NT control. (D–F) Investigation of the role of miR-29a-3p in VSMCs cultured under high phosphate conditions. (D) Vegfa mRNA expression measured using RT-qPCR, (E) mineralization assessed using ARS and spectrophotometric quantification, and (F) intracellular Ca2+ levels were quantified. Cells were transfected with either an empty vector (VE) or a Vegfa-overexpressing construct (OE), combined with a NT miRNA mimic or a miR-29a-3p mimic. All experiments were performed in five replicates, and error bars represent the SD. GAPDH was used as an internal control in RT-qPCR experiments. Scale bar = 100 µm.

Journal: Renal Failure

Article Title: miR-29a-3p/ Vegfa axis modulates high phosphate-induced vascular smooth muscle cell calcification

doi: 10.1080/0886022x.2025.2489712

Figure Lengend Snippet: Figure 3. Vegfa knockdown and miR-29a-3p overexpression mitigate high phosphate-induced VSMCs calcification. (A–C) Analysis of Vegfa knockdown effects in VSMCs cultured in normal media (control) or high phosphate conditions (Pi). (A) Vegfa mRNA levels were quantified via RT-qPCR. (B) ARS with corresponding spectrophotometric quantification to assess cellular mineralization. (C) Quantification of intracellular Ca2+ content. Cells were treated with small interfering RNA targeting Vegfa (siVegfa) or a NT control. (D–F) Investigation of the role of miR-29a-3p in VSMCs cultured under high phosphate conditions. (D) Vegfa mRNA expression measured using RT-qPCR, (E) mineralization assessed using ARS and spectrophotometric quantification, and (F) intracellular Ca2+ levels were quantified. Cells were transfected with either an empty vector (VE) or a Vegfa-overexpressing construct (OE), combined with a NT miRNA mimic or a miR-29a-3p mimic. All experiments were performed in five replicates, and error bars represent the SD. GAPDH was used as an internal control in RT-qPCR experiments. Scale bar = 100 µm.

Article Snippet: VSMCs recovered by centrifugation were homogenized and separated using 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (China National Pharmaceutical Group Corporation Chemical reagent Co., Ltd., China; Cat. #30166428). the proteins were then transferred to polyvinylidene fluoride membranes (Millipore Co., uSa; Cat. #ISEQ00010). the blots were stained with rabbit polyclonal antibodies against VEGFa (1:10,000; Proteintech, uSa; Cat. #19003-1-aP), and mouse monoclonal antibodies against β-actin (1:10,000, Servicebio, China; Cat. #Gb15001), followed by anti-rabbit IgG (1:10,000, SIMubIotECH, China; Cat. #S2001), and anti-mouse IgG horseradish peroxidase conjugates (1:10,000, abclonal, China; Cat. #aS003).

Techniques: Knockdown, Over Expression, Cell Culture, Control, Quantitative RT-PCR, Small Interfering RNA, Expressing, Transfection, Plasmid Preparation, Construct